Worldwide Market Reports

The Global Anticancer Drugs Market Is Expanding at an Exponential Pace Due to Promising Therapeutic Outcomes


Seattle, WA -- (SBWIRE) -- 11/05/2019 -- One of the leading causes of death is cardiovascular diseases followed by cancer. It is estimated that 1 out of 6 deaths is caused due to cancer. Within 3 years of the discovery of cancer its antidrug was invented hence proving that medical science has made enormous advances. On account of the growing demand for cancer curing drugs worldwide, the pharmaceuticals market, especially with regard to anti-cancer drugs is on hike.

Click Here For Downloading Free Sample Copy of This Report

Based on therapy, the anticancer drug market is segmented into immunotherapy, targeted therapy and chemotherapy. Immunotherapy is usually for treating melanoma, a dangerous form of skin cancer. The segment for targeted drugs accounts for more than 40% of share value in the global drugs market for anti-cancer. As compared to cytotoxic drugs, minimum side effects along with effective results and high specificity of the drugs are predicted to expand the growth of the segment by 2025.
 On the basis of cancer type, there is colorectal cancer, breast cancer, leukemia and lung cancer out of which lung cancer is predicted to expand at a strong CAGR of over XX% due to large number of lung cancer incidences and high prevalence and promising pipeline for non-small cell lung cancer (NSCLC) drugs during the forecast period.

Competitive Landscape View:
The study provides a decisive view of the Anticancer Drugs market by segmenting the market based on type, application, and region. All the segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2025. The regional segmentation includes the historic and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. This segmentation includes demand for Anticancer Drugs market based on all segments in all the regions and countries.

The key players involved in the market include
F. Hoffmann-La Roche Ltd
Novartis AG
Bayer AG
Eli Lilly and Company
Amgen Inc
Pfizer Inc
Merck & Co., Inc.
Takeda Pharmaceutical Company Limited

Why Buy?

The Anticancer Drugs Market report offers you perceptive data of the market and highlights its commercial landscape
It evaluates production processes, major bottlenecks, and solutions to reduce risks associated with R&D
The Anticancer Drugs Market report highlights pivotal factors that propel and hinder the market growth
It focuses on major growth strategies adopted by leading market players
The Anticancer Drugs Market report accurately projects the global market value and regional share during the forecast period

Click Here For Best Discount Offer On This Research Report

*If you have any special requirements, please let us know and we will offer you the report as you want.